The firm said that the technology contains an enclosed, sterile sorting chip that enables users to type cells according to biomarkers and sort them into separate outputs.
The recovery tool applies click chemistry-based DNA attachments on agarose beads to allow repetitive primer extension for specific gene targets.
The company, which previously focused on the development of multiplex PCR assays, is hoping to make its ATOM-seq technology available for research use later this year.
The number of US states legalizing cannabis for medical and recreational use is growing, expanding the market for pathogen detection solutions.
The SciLifeLab spinout uses barcoded probes, in situ rolling circle amplification, and sequencing by ligation to measure expression of a panel of genes.
In addition, a German court found in December that German NIPT company Cenata infringes Streck's patent.
Early-access users have used IDT's rhAmpSeq technology to create genetic marker maps for plants and to validate off target events in gene editing.
The platform, from a University of Illinois at Chicago-led team, separates circulating tumor cells from other cell types using size-dependent inertial migration.
The company signed distribution agreements covering 15 countries for its PlexWell technology and products for multiplexed NGS applications.
The firm's technology can perform in-droplet centrifugation, 10-second cell lysis, and sound wave-based PCR on the surface of an inexpensive polymer chip.
SeqOnce, which was founded in 2014, has developed a technology for NGS library preparation that it says is significantly quicker than competing methods.
The team evaluated BSTs from Norgen, Streck, Roche Diagnostics and PreAnalytix, and said Norgen's was the best in terms of genetic material storage.
The new grant from Innovate UK will fund development of a sample preparation system to support POC infectious disease pathogen detection.
Twist continues to invest in NGS while growing its core synthetic biology business, and has filed a countercomplaint in its ongoing litigation with Agilent.
The firm recognized revenues in fiscal Q1 2019 of $11.5 million, driven by rapid growth in its NGS products as well as its synthetic biology business.
Alliance Global will distribute Mawi's iSWAB biosampling technologies to the Middle East, Africa, and parts of Central and South Asia.
The device can process high-volume sputum samples for PCR-based Mycobacterium tuberculosis detection at smear-negative, culture-positive levels.
The companies will join certain of their respective technologies into a single product for low-pass whole-genome sequencing and genotype imputation.
The Boston-based startup will use the funds to expedite prototype development of its sample preparation technology and computational approach.
Circulomics, Bionano, Sage Science, RevoluGen, and others have been developing methods for extracting DNA hundreds of kilobases and up to megabases in length.
Rady Children's Institute for Genomic Medicine and Deloitte are looking into the use of drones to transport samples for testing.
Direct-to-consumer genetic testing firm 23andMe is laying off about 100 people.
Researchers from Northwestern University examined dust for antibiotic-resistance genes, New Scientist reports.
In Science this week: researchers present a computational method for predicting cellular differentiation state from single-cell RNA sequencing data, and more.